The NM_000152.5:c.725C>A variant in GAA is a missense variant predicted to cause substitution of Ala by Glu at amino acid 242 (p.Ala242Glu). The highest population minor allele frequency in gnomAD v2.1.1 is 0.00028 (7/24910 alleles) in the African population, which is lower than the ClinGen Lysosomal Diseases VCEP’s threshold for PM2 (<0.001), meeting this criterion (PM2_Supporting). The computational predictor REVEL gives a score of 0.528 which is neither above nor below the thresholds predicting a damaging (>0.7) or benign (<0.5) impact on GAA function (neither PP3 nor BP4 is met). It has not been reported in the literature as causative for GAA-related disease, but has been observed in 9 asymptomatic newborn screening cases by a clinical testing laboratory cases. In those cases, the c.1630G>A (p.Val544Met) variant (ClinVar Variation ID; 450358), classified as a variant of uncertain significance by the ClinGen LD VCEP on June 6, 2024), was always present suggesting that the two variants are in cis. There is a ClinVar entry for this variant (Variation ID: 642648). In summary, this variant meets the criteria to be classified as Uncertain significance for Pompe disease based on the ACMG/AMP criteria applied, as specified by the ClinGen Lysosomal Diseases Variant Curation Expert panel (specifications Version 2.0): PM2_supporting. (Classification approved by the ClinGen Lysosomal Diseases Variant Curation Expert Panel on May 21, 2024).